Overall survival after CRS-HIPEC for gastric cancer with synchronous peritoneal metastases
Dr. Luigi Marano
A multicenter study in Italy investigated outcomes after CRS-HIPEC for gastric cancer with synchronous peritoneal metastases. Factors associated with overall survival were completeness of cytoreduction score, Peritoneal Cancer Index score, receipt of neoadjuvant treatment, and cytology.
